Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-blind, Controlled Phase IIb Study of the Safety and Efficacy of ICT-107 in Patients with Glioblastoma.(Immunocellular)
Sponsored by Averion International Corporation
$303.3K Funding
1 People
External
Related Topics
immunotherapy,
glioblastoma,
clinical trial,
cancer treatment,
drug development
People
Baldassarre Stea
Principal Investigator (PI)
Radiation Oncology
﹒Department Head